Search for: "Genzyme Corporation" Results 21 - 40 of 71
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Apr 2011, 9:45 am by Gene Quinn
., Vice President and Chief Patent Counsel, Genzyme Corporation, lead off by pointing out something that everyone largely seems to agree with, namely that the facts of the case are still largely in dispute, which makes me wonder why would the Supreme Court take such a case. [read post]
11 Oct 2010, 7:38 am by Sonya Hubbard
A lot of companies are jumping into M&A deals willingly, but that’s certainly not the case for Genzyme Corporation (GENZ), which is doing its best to fend off Sanofi-Aventis SA’s (SNY) $18.5 billion hostile takeover proposal – despite the buckets of cash that Genzyme’s executives would get in the process. [read post]
1 Dec 2009, 9:45 am by Karen E. Keller
Genzyme Corporation (patent infringement) 10/15: Tristrata Technology Inc. v. [read post]
30 Oct 2018, 1:58 am by Simon Holzer
The Federal Patent Court issued a PI based on Genzyme Corporation’s Swiss SPC for sevelamer, although it was unclear whether the Swiss Institute of Intellectual Property (IPI) had approved an application for re-establishment of rights correctly when Genzyme Corporation applied for its SPC. [read post]
30 Jun 2014, 4:23 am by Lawrence B. Ebert
Dow Chemical Company DuPont Eastman Chemical Company Electronics for Imaging Eli Lilly and Company Exxon Mobil Corporation General Electric General Mills Genzyme GlaxoSmithKline Henkel Corporation Hoffman-La Roche Illinois Tool Works Inc. [read post]
15 Mar 2016, 9:00 am by Suzette Pringle
On March 4, 2016, the Second Circuit affirmed the dismissal of two related securities actions against Sanofi Pharmaceuticals, its predecessor Genzyme Corporation, and three company executives (collectively, “Sanofi”). [read post]
29 Oct 2010, 7:00 am
Malkin and Christopher Gosselin On October 19, FDA granted a citizen petition filed on behalf of Genzyme Corporation ("Genzyme") requesting FDA to confirm that a second 30-month stay would issue following a subsequent Paragraph IV notice sent for a reformulated generic version of Hectoral® injection (doxercalciferol). [read post]
8 Jun 2010, 8:14 am by Brian Wm. Higgins
District Court for the District of Maryland in May 2010 (source: Justia.com): Patent dockets: Genzyme Corporation v. [read post]
30 Sep 2009, 2:58 am
  If Genzyme’s interpretation of the policy were correct, she found, "a corporation merely need issue several classes of shares, cancel one class in an arguably unfair way, and then demand that the insurer pick up the tab. [read post]
1 May 2014, 9:09 pm by David Jensen
”He also said, “At Osiris, we've built a culture where patients come first, and we've accomplished much over the last year: We formed the largest stem-cell partnership ($1.4 billion) to date with Genzyme Corporation; we created and sold our first commercial stem-cell product line for $85 million in cash; and we won a $227 million Department of Defense contract. [read post]
2 Dec 2010, 12:29 am by Kevin LaCroix
A November 22, 2010 Eastern District of Virginia decision, applying Kansas law, in a case involving Sprint Nextel Corporation, addressed this issue. [read post]
25 Oct 2010, 10:52 am by FDABlog HPM
Karst –       FDA’s recent decision to grant an April 27, 2010 citizen petition submitted on behalf of Genzyme Corporation (“Genzyme”) concerning the Agency’s ability to approve Cobrek Pharmaceuticals, Inc. [read post]